Acute neurological injury caused by interruption of blood flow to brain tissue (ischemic stroke, ~87% of cases) or vascular rupture (hemorrhagic stroke, ~13%), resulting in excitotoxic cell death, inflammatory cascade activation, and neurological deficit. The extent of permanent damage is determined not by the initial ischemic event itself, but by the inflammatory resolution capacity—specifically specialized pro-resolving mediators production, macrophages polarization state, and efferocytosis efficiency during the critical 24-72 hour window post-insult.
Imagine a city neighborhood suddenly loses power—all refrigerators stop, all alarm systems fail, all communication goes dark. Within minutes, shops start dumping spoiled goods into the street (neurons releasing DAMPs and glutamate). This attracts scavengers from neighboring districts who start swarming in, some to genuinely clean up (M2 macrophages), but many just to loot and cause more chaos (M1 macrophages, neutrophils).
The critical question isn't whether scavengers arrive—they always do, even when the walls (blood-brain barrier) are still standing, because they come through underground tunnels from the skull basement (bone marrow channels). The question is: does the city have enough competent cleanup crews and conflict resolution mediators (specialized pro-resolving mediators, Treg cells) to shift the scavengers from destructive to constructive mode? If the city had weak infrastructure to begin with—crumbling roads (endothelial dysfunction), chronically understaffed emergency services (HPA axis exhaustion), chronic low-level gang activity (chronic low-grade inflammation)—the post-blackout chaos will be catastrophic. But a city with robust emergency protocols can turn the same power outage into a managed, recoverable event.
Initial injury (0-6 minutes):
- Arterial occlusion (thrombus/embolus) → cerebral blood flow <20% normal → ATP depletion → failure of Na⁺/K⁺-ATPase
- Ionic equilibrium collapse → neuronal depolarization → voltage-gated Ca²⁺ channel opening → intracellular Ca²⁺ overload (>1μM, normally 100nM)
- Synaptic glutamate release → NMDA receptor and AMPA receptor activation → further Ca²⁺ influx
- excitotoxicity: Ca²⁺ activates calpains, phospholipases, endonucleases → membrane breakdown, DNA fragmentation
Oxidative cascade (minutes-hours):
Inflammatory activation (1-24 hours):
- Dying neurons release DAMPs (ATP, HMGB1, mitochondrial DNA, heat shock proteins)
- Resident microglia activation via TLR4, RAGE, P2X3 Receptor
- Microglial M1 polarization → IL-1β, TNF-α, IL-6, nitric oxide, prostaglandin E2 production
- blood-brain barrier breakdown: matrix metalloproteinases (MMP-2, MMP-9) degrade tight junction proteins (ZO-1, occludin) and basement membrane
- Endothelial ICAM-1, VCAM-1 upregulation → leukocyte adhesion
Peripheral immune infiltration (6-72 hours):
- neutrophils arrive first (peak 1-3 days) via blood-brain barrier and skull bone marrow-meningeal route
- Neutrophil NETosis → extracellular DNA traps worsen vascular occlusion
- monocytes recruited via CCL2 gradient → differentiate to infiltrating macrophages
- T cell infiltration (CD4⁺ effectors worsen injury, Treg cells promote resolution)
- Alternative route: meninges lymphatic drainage becomes bidirectional highway for immune trafficking
graph TD
A[Arterial Occlusion] --> B[ATP Depletion]
B --> C["Na+/K+ Pump Failure"]
C --> D[Membrane Depolarization]
D --> E[Glutamate Release]
D --> F["Ca²⁺ Channel Opening"]
E --> F
F --> G["Intracellular Ca²⁺ >1μM"]
G --> H[Calpain Activation]
G --> I[Mitochondrial Overload]
H --> J[Membrane Breakdown]
I --> K[ROS Production]
K --> L[Lipid Peroxidation]
I --> M[Cytochrome c Release]
M --> N[Caspase Cascade]
J --> O[DAMP Release]
N --> O
O --> P[Microglial TLR4 Activation]
P --> Q[M1 Polarization]
Q --> R[Pro-inflammatory Cytokines]
R --> S[MMP-9 Production]
S --> T[BBB Breakdown]
T --> U[Neutrophil Infiltration]
U --> V[Secondary Injury Amplification]
W[SPM Production?] -.Alternative Path.-> X[M2 Polarization]
X --> Y[Debris Clearance]
Y --> Z[Resolution & Repair]
Resolution or chronicization (72 hours - weeks):
- If SPM production adequate: RvD1, RvD2, MaR1, LXA4 bind ALX-FPR2 receptor on neutrophils/macrophages
- Counter-regulate NF-κB, enhance efferocytosis, promote M2 shift
- M2 macrophages secrete IL-10, TGF-beta, VEGF → angiogenesis and neurogenesis
- If SPM deficient: Persistent M1 dominance → chronic neuroinflammation → progressive tissue loss → larger final infarct
- Vascular rupture (usually from chronic hypertension-induced arteriopathy)
- Blood extravasation → mass effect, increased intracranial pressure
- Heme breakdown products (free iron) → oxidative stress amplification via Fenton reaction
- Thrombin generation → direct neurotoxicity + inflammatory activation
Stroke as evolutionary mismatch disease:
70% of strokes are preventable through lifestyle modification—this is not merely optimistic; it's documented reality (Willett, Science 2002). Stroke represents the terminal catastrophic manifestation of cumulative evolutionary mismatch: chronic sympathetic nervous system dominance (ancestral short-term threat response applied chronically), metabolic syndrome (permanent energy surplus without energy expenditure), chronic low-grade inflammation (persistent sterile inflammatory activation), and endothelial dysfunction (vascular lining adapted for intermittent stress, not 24/7 assault).
Risk factor cascade:
- hypertension (present in 77% of stroke patients): chronic vascular shear stress → endothelial injury → atherosclerosis
- type 2 diabetes: AGE accumulation → vascular inflammation, microvascular damage
- Chronic HPA axis activation → cortisol excess → insulin resistance, visceral adiposity, hypertension
- chronic low-grade inflammation: baseline CRP >3 mg/L increases stroke risk 2-fold
- Smoking, physical inactivity, poor diet quality—all modifiable
Post-stroke prognosis determined by resolution capacity:
Patients with higher baseline omega-3 index (>8%) and robust specialized pro-resolving mediators production show:
- 40% smaller final infarct volumes
- Better functional recovery at 90 days
- Reduced risk of post-stroke depression (itself an inflammatory condition)
Clinical intervention windows:
- Acute phase (0-24h): thrombolysis (tPA) if <4.5h, thrombectomy if <24h for large vessel occlusion
- Inflammatory modulation (24-72h): THIS is where cPNI perspective offers novelty—omega-3 supplementation (EPA+DHA 2-4g/day), aspirin (triggers aspirin-triggered resolvins), potentially exogenous SPMs
- Recovery phase (weeks-months): neuroplasticity support via BDNF enhancement (exercise, omega-3s, fasting protocols), continued anti-inflammatory nutrition
Skull bone marrow discovery implications:
The 2018 finding that myeloid cells infiltrate CNS via direct skull bone marrow-meningeal channels even with intact blood-brain barrier revolutionizes stroke pathophysiology. This explains rapid immune response and suggests bone marrow health (influenced by metabolic syndrome, chronic inflammation) as upstream stroke risk modulator.
Connection to lifestyle disease concept:
Stroke shares >70% preventability with colon cancer, coronary heart disease, type 2 diabetes—the "welfare diseases" quartet. All four reflect chronic activation of systems designed for acute, intermittent stress: immune system stuck in low-grade activation, HPA axis chronically firing, sympathetic tone persistently elevated.
- Ischemic stroke comprises ~87% of cases; hemorrhagic ~13%
-
70% of strokes are preventable through diet, exercise, stress management, and metabolic optimization
- Penumbra (salvageable tissue) remains viable 3-6 hours after core infarction; intervention window
- Glutamate concentration in ischemic core reaches >100μM (normal ~1μM), triggering excitotoxic cascade
- Intracellular Ca²⁺ rises from 100nM to >1μM within minutes of ischemia
- MMP-9 peaks 24-48h post-stroke, correlating with blood-brain barrier breakdown severity
- Neutrophil infiltration peaks days 1-3; monocyte/macrophage infiltration peaks days 3-7
- Patients with omega-3 index >8% show 40% smaller infarct volumes compared to <4%
- Chronic CRP >3 mg/L doubles stroke risk; CRP >10 mg/L triples it
- Post-stroke depression affects 30-50% of survivors, mediated by persistent neuroinflammation
- Skull bone marrow supplies ~40% of infiltrating myeloid cells post-stroke via meningeal channels
- SPM (RvD1, MaR1) levels at 24h post-stroke predict 90-day functional outcomes
- Stroke mortality has declined 60% since 1970s in high-income countries—primarily through risk factor management
- Every 1mmHg reduction in population blood pressure prevents ~10,000 strokes annually in US
- Time is brain: 1.9 million neurons die per minute during untreated ischemic stroke
- blood-brain barrier — stroke triggers MMP-9-mediated tight junction degradation; BBB permeability allows peripheral immune infiltration and predicts hemorrhagic transformation risk
- neuroinflammation — stroke is paradigmatic neuroinflammatory cascade: DAMP release → microglial activation → cytokine storm → secondary injury amplification
- excitotoxicity — glutamate-mediated Ca²⁺ overload is primary mechanism of neuronal death in ischemic penumbra; NMDA receptor antagonists neuroprotective in animal models but clinically challenging
- oxidative stress — ROS generation from mitochondrial dysfunction and inflammatory cell NADPH oxidase drives lipid peroxidation and amplifies injury beyond initial ischemic core
- macrophages — infiltrating monocyte-derived macrophages determine stroke outcome: M1 worsen tissue damage via IL-1β/TNF-α, M2 support repair via IL-10/TGF-β and debris clearance
- microglia — resident CNS sentinels activated within minutes by ATP and HMGB1; early responders that can shift from surveillance to inflammatory amplification
- specialized pro-resolving mediators — RvD1, MaR1, LXA4 production capacity predicts stroke recovery; SPM deficiency correlates with larger infarcts and worse functional outcomes
- metabolic syndrome — upstream driver of stroke risk through multiple pathways: endothelial dysfunction, chronic inflammation, insulin resistance, hypertension, dyslipidemia
- hypertension — present in 77% of stroke patients; chronic elevated shear stress damages endothelium, promotes atherosclerosis, increases vessel rupture risk
- endothelial dysfunction — impaired NO production, increased adhesion molecule expression, prothrombotic state; measurable years before stroke event
- inflammation — chronic low-grade inflammation (CRP >3 mg/L) doubles stroke risk; inflammatory priming worsens post-stroke inflammatory cascade
- HPA axis — chronic cortisol elevation increases stroke risk via vascular resistance, insulin resistance, visceral adiposity; stress management interventions reduce risk
- sympathetic nervous system — chronic sympathetic dominance elevates blood pressure, increases platelet reactivity, promotes endothelial dysfunction; meditation/breathing reduce stroke risk
- lifestyle disease — stroke exemplifies mismatch disease: >70% preventable through ancestral-aligned lifestyle (whole foods, movement, stress management, social connection)
- neutrophils — first peripheral immune cells to infiltrate (6-24h); NETosis worsens microvascular occlusion; neutrophil-lymphocyte ratio predicts stroke severity
- T cells — CD4⁺ effector T cells (Th1, Th17) worsen injury via IFN-γ and IL-17; regulatory T cells promote resolution via IL-10 and TGF-β
- DAMPs — HMGB1, ATP, mitochondrial DNA, HSPs released by dying neurons activate TLR4/RAGE on microglia and infiltrating immune cells, amplifying neuroinflammation
- mitochondrial dysfunction — Ca²⁺ overload disrupts electron transport chain, increases ROS production, triggers cytochrome c release and apoptosis; mitochondrial health predicts resilience
- meninges — newly appreciated as immune trafficking highway; skull bone marrow connects directly to meningeal lymphatics, allowing rapid myeloid cell recruitment even with intact BBB
- type 2 diabetes — increases stroke risk 2-4 fold via multiple mechanisms: advanced glycation end-products, microvascular damage, chronic inflammation, coagulation abnormalities
- colon cancer — shares >70% preventability with stroke through identical lifestyle interventions; both exemplify welfare diseases responding to evolutionary mismatch correction
- chronic stress — psychological stress increases stroke risk via HPA axis activation, sympathetic dominance, inflammation, hypertension; stress reduction interventions demonstrably protective
- efferocytosis — efficient clearance of apoptotic neutrophils and debris by M2 macrophages prevents secondary necrosis and chronic inflammation; SPMs enhance efferocytosis capacity
- gut microbiome — dysbiosis correlates with stroke risk via trimethylamine N-oxide (TMAO) production, systemic inflammation, and metabolic endotoxemia
- exercise — single most effective stroke prevention intervention: improves endothelial function, reduces blood pressure, enhances insulin sensitivity, reduces inflammation
- Module 1 — Evolutionary medicine foundations; stroke as lifestyle disease; preventability statistics
- Module 2 — Neuroimmune mechanisms; skull bone marrow-meningeal axis; inflammatory resolution determining outcomes